Press release
Intravenous (IV) Iron Drugs Market 2020 Size, Share, Regional Growth, Industry Outlook and Forecast till 2026
Intravenous (IV) Iron Drugs Market
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/intravenous-iv-iron-drugs-market-101236
According to the report, the rising prevalence of anemia is predicted to contribute positively to the global intravenous (IV) iron drugs market revenue. symptoms of anemia include loss of energy and fatigue, difficulty in concentration, pale skin and dizziness, insomnia and cramps. According to a survey conducted by the Vitamin and Mineral Nutrition Information System. In 2017, approximately 30% of women and children in developing countries suffered from anemia.
Highlights of the Intravenous (IV) Iron Drugs Market Report Include:
o Microscopic study of the various factors driving and restraining the market
o Careful classification and research of the market segments
o Accurate computation of market figures
o Comprehensive analysis of the regional dynamics and competitive landscape
Key Players Operating in The Intravenous (IV) Iron Drugs Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
o Daiichi Sankyo, Inc.
o Sanofi
o AMAG Pharmaceuticals, Inc
o Allergan
o Nippon Shinyaku Co., Lt
o Pharmacosmos A/S.
o And others.
North America dominated the intravenous (IV) iron drugs market in 2018 due to the increasing prevalence of anemia and rising cases of associated diseases such as celiac disease along with inflammatory bowel disease. Moreover, high healthcare expenditure, access to advanced intravenous (IV) iron drugs and rising demand for preventive medical care will further favor growth in North America. Asia Pacific is predicted grow at a remarkable rate during the forecast period owing to the increasing awareness and cases of anemia and growing access to intravenous (IV) iron drugs. The rising prevalence of acute and severe diseases such as inflammatory bowel disease will also accelerate growth in North America. Latin America and the Middle East and Africa are expected to grow at a relatively lower CAGR during the forecast period.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/intravenous-iv-iron-drugs-market-101236
FDA Approval for I.V. TRIFERIC? Will Enable Growth
Rockwell Medical, Inc. a biopharmaceutical and therapeutic company based in Wixom, Michigan launched a New Drug Application (NDA) for its Intravenous (I.V.) formulation of TRIFERIC? with a PDUFA (Prescription Drug User Fee Act) after receiving approval from the Food and Drug Administration (FDA). Dialysate Triferic is mixed with liquid bicarbonate to deliver iron to patients via the dialysate, while I.V. Triferic is designed for intravenous administration to patients. The launch of I.V. TRIFERIC? by Rockwell Medical, Inc. will boost the global intravenous (IV) iron drugs market revenue during the forecast period.
Intravenous (IV) Iron Drugs Market Segmentation:
By Type
o Iron Sucrose
o Dextran
o Ferric Carboxyl Maltose
o Ferric Gluconate
o Others
By Application
o Gynecology
o Oncology
o Nephrology
o Others
By End User
o Hospitals
o Ambulatory Surgery Centers
o Homecare Settings
o Others
By Geography
o North America (USA and Canada)
o Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
o Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
o Latin America (Brazil, Mexico and Rest of Latin America)
o Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Order Full Report: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/intravenous-iv-iron-drugs-market-101236
Related Reports:
DNA Sequencing Market 2020: Global Size, Top Key Companies, Industry Analysis by Trends, Future Growth and Regional Forecasts Research Report 2026- https://www.marketwatch.com/press-release/dna-sequencing-market-2020-global-size-top-key-companies-industry-analysis-by-trends-future-growth-and-regional-forecasts-research-report-2026-2020-02-11
Parkinson's Disease Drugs Market by Top Key Players are Pfizer, Roche, Merck, Novartis, Orion Pharma,UCB and more Forecast by 2026- https://www.marketwatch.com/press-release/parkinsons-disease-drugs-market-by-top-key-players-are-pfizer-roche-merck-novartis-orion-pharmaucb-and-more-forecast-by-2026-2019-12-06
About Us:
Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous (IV) Iron Drugs Market 2020 Size, Share, Regional Growth, Industry Outlook and Forecast till 2026 here
News-ID: 1927556 • Views: …
More Releases from Fortune Business Insights Private Limited
Electro-Optical/Infrared Systems Market Will Witness A Demand Increase, Led By T …
The global electro-optical/infrared (EO/IR) systems market size is expected to reach USD 20.36 billion by 2026, exhibiting a CAGR of 5.84% during the forecast period. The growing necessity to improve target identification, assess threats, and monitoring in different weather conditions will spur opportunities for the market during the forecast period.
The increasing application of EO/IR in fire control system, airborne homeland security, search and rescue, surveillance, and intelligence, surveillance, target…
Cryogenic Equipment Market 2022 In-depth Research with Emerging Growth Trends, R …
This research study can be used by all participants in the Cryogenic Equipment Market as it covers all major and minor aspects of the current and future market competition. It can also prove very beneficial for stakeholders in view of the range of courses on offer and a detailed analysis of the expected growth strategies of the players in the coming years. According to the data by Ecotricity, crude oil…
Natural Zeolites Market Trends, Top Key Players, Business Opportunities, Industr …
The global natural zeolites market size is expected to gain momentum owing to the rising demand from construction industry during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, "Natural Zeolites Market, 2022-2029." They are aluminosilicate minerals with a microporous surface that allows them to absorb a wide range of cations, including water. They are mined using traditional open-pit mining processes and they…
Lemon Oil Market Share, Demand, Top Players, Industry Size, Future Growth By 202 …
The global lemon oil market size is expected to gain momentum owing to the rising demand in cosmetic & personal care during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, "Lemon Oil Market, 2022-2029." Liquid sunshine is another name for lemon oil. It's a citrus essential oil with a fresh scent that comes from the citrus lemon plant. The oil is extracted…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
